EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA

被引：216
|
作者：
MITCHELL, MS
KEMPF, RA
HAREL, W
SHAU, H
BOSWELL, WD
LIND, S
BRADLEY, EC
机构：
[1] UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90033
[4] CETUS CORP,EMERYVILLE,CA 94608
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 03期
关键词：
D O I：
10.1200/JCO.1988.6.3.409
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：409 / 424
页数：16
相关论文
共 50 条
  • [11] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
  • [12] ACUTE INTERSTITIAL NEPHRITIS DURING CONTINUOUS INTRAVENOUS ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2
    DIEKMAN, MJM
    VLASVELD, LT
    KREDIET, RT
    RANKIN, EM
    ARISZ, L
    NEPHRON, 1992, 60 (01): : 122 - 123
  • [13] Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma
    Demir, G
    Demirelli, F
    Özgüroglu, M
    Molinas-Mandel, N
    Büyükünal, E
    Tüzüner, N
    Serdengeçti, S
    Berkarda, B
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1998, 14 (03): : 163 - 168
  • [14] Effects of low-dose recombinant interleukin-2 in human malignancies
    Lissoni, P
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 : S115 - S120
  • [15] Low-Dose Interleukin-2 and HCV-Induced Vasculitis
    Oo, Ye Htun
    Mutimer, David
    Adams, David H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14): : 1353 - 1354
  • [16] Low-Dose Interleukin-2 Treatment of Refractory Lupus Nephritis
    Zhang, Xia
    He, Jing
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [17] Low-dose interleukin-2: A potential treatment for pemphigus vulgaris
    Long, Hai
    Liao, Jieyue
    Yang, Miao
    Wang, Xin
    Zhang, Guiying
    Lu, Qianjin
    AUTOIMMUNITY REVIEWS, 2021, 20 (10)
  • [18] Low-dose interleukin-2 therapy in systemic lupus erythematosus
    La Cava, Antonio
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (03): : 150 - 156
  • [19] Response rates of patients with metastatic melanoma to high-dose intravenous interleukin-2 after prior exposure to alpha-interferon or low-dose interleukin-2
    Weinreich, DM
    Rosenberg, SA
    JOURNAL OF IMMUNOTHERAPY, 2002, 25 (02): : 185 - 187
  • [20] Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer
    Quan, Walter D. Y., Jr.
    Quan, Francine M.
    King, Linda A.
    Walker, Paul R.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (01) : 108 - 113
12345